Literature DB >> 15617019

Fluoxetine use in early pregnancy.

Bengt Källén.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15617019     DOI： 10.1002/bdrb.20025

Source DB:  PubMed          Journal:  Birth Defects Res B Dev Reprod Toxicol        ISSN： 1542-9733


× No keyword cloud information.
  8 in total

1.  The use of central nervous system active drugs during pregnancy.

Authors:  Bengt Källén; Natalia Borg; Margareta Reis
Journal:  Pharmaceuticals (Basel)       Date:  2013-10-10

2.  Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems.

Authors:  Michael A Thomas; Parag P Joshi; Rebecca D Klaper
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2011-06-06       Impact factor: 3.228

3.  Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.

Authors:  Anthony Wemakor; Karen Casson; Ester Garne; Marian Bakker; Marie-Claude Addor; Larraitz Arriola; Miriam Gatt; Babak Khoshnood; Kari Klungsoyr; Vera Nelen; Mary O'Mahoney; Anna Pierini; Anke Rissmann; David Tucker; Breidge Boyle; Lolkje de Jong-van den Berg; Helen Dolk
Journal:  Eur J Epidemiol       Date:  2015-07-07       Impact factor: 8.082

4.  Prevalence and patterns of antidepressant drug use during pregnancy.

Authors:  Tessa Ververs; Hans Kaasenbrood; Gerard Visser; Fred Schobben; Lolkje de Jong-van den Berg; Toine Egberts
Journal:  Eur J Clin Pharmacol       Date:  2006-08-08       Impact factor: 2.953

Review 5.  SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome.

Authors:  Salvatore Gentile
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007.

Authors:  Kara N D Polen; Sonja A Rasmussen; Tiffany Riehle-Colarusso; Jennita Reefhuis
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-12-26

Review 7.  Safety of selective serotonin reuptake inhibitors in pregnancy.

Authors:  Sura Alwan; Jan M Friedman
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

8.  Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities.

Authors:  Cornelle W Noorlander; Frederique F T Ververs; Peter G J Nikkels; Cees J A van Echteld; Gerard H A Visser; Marten P Smidt
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.